TELA Bio, Inc. Balance Sheet
TELA|7 years of annual SEC 10-K data (FY2019-FY2025)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 7 fiscal years. All figures from audited SEC 10-K filings.
TELA Bio, Inc. had $81M in total assets and $28M in shareholders' equity as of FY2025. Total debt was $56M against $51M in cash, resulting in $5M net debt.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score -0.23 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $50.8M | $52.7M | $46.7M | $42.0M | $43.9M | $45.3M | $45.3M |
| Inventory | $11.0M | $12.8M | $13.2M | $11.8M | $7.7M | $3.9M | $4.6M |
| Current Assets | $75.6M | $78.1M | $71.7M | $62.4M | $59.1M | $83.2M | $64.3M |
| PP&E (Net) | $2.2M | $2.3M | $2.0M | $1.7M | $1.2M | $626.0K | $677.0K |
| Total Assets | $81.4M | $86.6M | $78.0M | $67.9M | $62.5M | $86.5M | $67.9M |
| Current Liabilities | $18.0M | $15.6M | $17.0M | $12.4M | $10.6M | $6.6M | $6.7M |
| Total Debt | $55.7M | $41.1M | $40.5M | $39.9M | $31.5M | $30.8M | - |
| Shareholders' Equity | $28.5M | $14.3M | $20.1M | $49.0M | $31.0M | -$137.9M | -$108.2M |